The MRC funding will help with the next steps, including equipment needed to manufacture experimental mRNA cancer vaccines and test whether the AI’s predictions work in patient samples. The aim is to determine whether vaccine targets selected by AI can generate strong anti-cancer immune responses.
Source link
Leave a comment